WALTHAM, Mass., Oct. 26, 2018 /PRNewswire/ -- Fresenius Medical Care's Renal Therapies Group today announced the results of four studies utilizing the Crit-Line ® monitor that examine how relative ...
WALTHAM, Mass., July 27, 2022 /PRNewswire/ -- Fresenius Medical Care North America's (FMCNA) Renal Therapies Group today announced the availability of the CombiSet SMARTECHTM, the first available ...
Please provide your email address to receive an email when new articles are posted on . Blood volume monitoring-guided hemodialysis decreased hospital stay by 2 days. Patients treated with the therapy ...